Estimating a normal reference range for serum B-cell maturation antigen levels for multiple myeloma patients

Br J Haematol. 2021 Mar;192(6):1064-1067. doi: 10.1111/bjh.16673. Epub 2020 Apr 22.

Abstract

The serum B-cell maturation antigen (sBCMA) has been identified as a novel serum biomarker for patients with multiple myeloma. However, no study has yet established a reference range for sBCMA levels. Its levels were determined in 196 healthy subjects and showed a right-tailed distribution with a median value of 37·51 ng/ml with a standard deviation of 22·54 ng/ml (range 18·78-180·39 ng/ml). Partitioning of subgroup reference ranges was considered but determined to be irrelevant. A non-parametric method using the median ± 2 standard deviations suggests using a universal reference interval of <82·59 ng/ml.

Keywords: multiple myeloma; reference range; serum BCMA.

MeSH terms

  • Adult
  • Aged
  • B-Cell Maturation Antigen / blood*
  • Biomarkers, Tumor / blood*
  • Female
  • Humans
  • Male
  • Middle Aged
  • Multiple Myeloma / blood*
  • Neoplasm Proteins / blood*

Substances

  • B-Cell Maturation Antigen
  • Biomarkers, Tumor
  • Neoplasm Proteins
  • TNFRSF17 protein, human